Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-019-02243-w.pdf
Reference52 articles.
1. Modaresi A, Nafar M, Sahraei Z (2015) Oxidative stress in chronic kidney disease. Iran J Kidney Dis 9(3):165–179
2. Locatelli F, Marcelli D, Conte F, Amico DM, Del Vecchio L, Limido A, Malberti F, Spotti D (2000) Cardiovascular disease in chronic renal failure: the challenge continues. Nephrol Dial Transplant 15(90005):69–80
3. Bossola M, Tazza L (2015) Wishful thinking: the surprisingly sparse evidence for a relationship between oxidative stress and cardiovascular disease in hemodialysis patients. Semin Dial 28(3):224–230
4. Kielstein JT, FroÈlich JC, Haller H, Fliser D (2001) ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? Nephrol Dial Transplant 16(9):1742–1745
5. El-Mesallamy HO, Hamid SGA, Gad MZ (2008) Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by l-arginine intake. Kidney Blood Press Res 31(3):189–195
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease;Scientific Reports;2023-08-18
2. Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study;Clinical Cardiology;2023-03-29
3. Clinical significance of serum CDC42 in the prediction of uremic vascular calcification incidence and progression;Libyan Journal of Medicine;2023-03-29
4. Effects of Febuxostat on Markers of Endothelial Dysfunction and Renal Progression in Patients with Chronic Kidney Disease;2023-03-08
5. Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis;Frontiers in Pharmacology;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3